In Vivo Engineering of Therapeutic Cells Summit 2023
By
Hanson Wade
2 Followers
Follow
Event Details
In Vivo Engineering of Therapeutic Cells Summit 2023
Returning to Boston for 2023, the 2nd In Vivo Engineering of Therapeutic Cells Summit is the only industry focused meeting place future innovations in the cell and gene space front and centre - dedicating time to explore the blockbuster potential of in vivo cell engineering with a key focus on optimizing delivery, targeting and specificity.
Get caught up to speed on this dynamic industry with expertise shared from the likes of Capstan Therapeutics, Interius Biotherapeutics, Vector Biopharma and many others as the titans of industry unite to showcase the latest delivery technologies that are set to transform the cell and gene space.
Join your community of 100+ industry experts to revolutionise the future of modern medicine, bringing affordable and transformative cell therapies to patients at need globally.
URLs:
Website: https://go.evvnt.com/1635974-0?pid=10018
Brochure: https://go.evvnt.com/1635974-2?pid=10018
Tickets: https://go.evvnt.com/1635974-3?pid=10018
Prices:
Drug Developer - Conference + Workshop Day: USD 3296.00,
Drug Developer - Conference Only: USD 2099.00,
Academic - Conference + Workshop Day: USD 2596.00,
Academic - Conference Only: USD 1699.00,
Service Provider - Conference + Workshop Day: USD 4296.00,
Service Provider - Conference Only: USD 2799.00
Speakers: Adi Barzel Professor, Co-Founder, Tel Aviv University, Logic Bio, Tabby Therapeutics, Adrian Bot, CSO, Capstan Therapeutics, Anna French, Partner, Qiming Venture Partners, Artavazd Arumov, VP, Qiming Venture Partners, Bakul Gupta CEO, Co-Founder, ImmTune Therapies Limited, Cecile Bauche, Founder, CSO, Alaya Bio, Cory Sago, CEO, Stealth Mode Biotech, David Johnson, CEO, GigaMune, David Peritt, President and Co-Founder, Lupagen, Gregory Newby, Assistant Professor, Johns Hopkins Department of Genetic Medicine, Haig Aghajanian, VP, Research Capstan Therapeutics, Jagesh Shah, VP, Gene Therapy, Sana Biotechnology, James Edinger, Senior VP, Preclinical Science, Mustang Bio, Lorenz Mayr, CEO, Vector BioPharma, Mary Haak-Frendscho, CEO, Spotlight Therapeutics, Mary Janatpour, EVP and CSO, Spotlight Therapeutics, Owen Fenton, Assistant Professor, University of North Carolina, Phil Johnson, President and CEO, Interius BioTherapeutics, Renaud Vaillant, President and Co-Founder, Alaya Bio, Sheena Smith, Head of Program Management, Vector BioPharma
Get caught up to speed on this dynamic industry with expertise shared from the likes of Capstan Therapeutics, Interius Biotherapeutics, Vector Biopharma and many others as the titans of industry unite to showcase the latest delivery technologies that are set to transform the cell and gene space.
Join your community of 100+ industry experts to revolutionise the future of modern medicine, bringing affordable and transformative cell therapies to patients at need globally.
URLs:
Website: https://go.evvnt.com/1635974-0?pid=10018
Brochure: https://go.evvnt.com/1635974-2?pid=10018
Tickets: https://go.evvnt.com/1635974-3?pid=10018
Prices:
Drug Developer - Conference + Workshop Day: USD 3296.00,
Drug Developer - Conference Only: USD 2099.00,
Academic - Conference + Workshop Day: USD 2596.00,
Academic - Conference Only: USD 1699.00,
Service Provider - Conference + Workshop Day: USD 4296.00,
Service Provider - Conference Only: USD 2799.00
Speakers: Adi Barzel Professor, Co-Founder, Tel Aviv University, Logic Bio, Tabby Therapeutics, Adrian Bot, CSO, Capstan Therapeutics, Anna French, Partner, Qiming Venture Partners, Artavazd Arumov, VP, Qiming Venture Partners, Bakul Gupta CEO, Co-Founder, ImmTune Therapies Limited, Cecile Bauche, Founder, CSO, Alaya Bio, Cory Sago, CEO, Stealth Mode Biotech, David Johnson, CEO, GigaMune, David Peritt, President and Co-Founder, Lupagen, Gregory Newby, Assistant Professor, Johns Hopkins Department of Genetic Medicine, Haig Aghajanian, VP, Research Capstan Therapeutics, Jagesh Shah, VP, Gene Therapy, Sana Biotechnology, James Edinger, Senior VP, Preclinical Science, Mustang Bio, Lorenz Mayr, CEO, Vector BioPharma, Mary Haak-Frendscho, CEO, Spotlight Therapeutics, Mary Janatpour, EVP and CSO, Spotlight Therapeutics, Owen Fenton, Assistant Professor, University of North Carolina, Phil Johnson, President and CEO, Interius BioTherapeutics, Renaud Vaillant, President and Co-Founder, Alaya Bio, Sheena Smith, Head of Program Management, Vector BioPharma
Entry Fees
Free Registration
Categories
Event Frequency
One Time
Event Timings
(GMT-4:00) Eastern Time (US and Canada)
08:30 AM - 04:30 PM (Jul 10, Jul 11, Jul 12) (General)
Speakers
Organizer
Hanson Wade
2 Followers
Follow
Hanson Wade specialises in bringing people together through outstanding business conferences and year round community contact.
Comments on In Vivo Engineering of Therapeutic Cells Summit 2023
You must Login to write a comment.
Peoples Interested in Visit
0 Peoples Interested to Visit
Event Location
Hyatt Regency Boston
1, Avenue de Lafayette, Downtown, Boston ,
Boston 02111, Massachusetts, United States
Boston 02111, Massachusetts, United States
Official Link :